Cargando…

Characterization of immune landscape in papillary thyroid cancer reveals distinct tumor immunogenicity and implications for immunotherapy

Although the vast majority of patients with papillary thyroid cancer (PTC) have a favorable prognosis when conventional treatments are implemented, local recurrence and distant metastasis of advanced PTCs still hamper the survival and clinical management in certain patients. As immune checkpoint blo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Jing, Shi, Run, Zhang, Xiaowen, Fang, Da, Rauch, Josefine, Lu, Shun, Wang, Xuanbin, Käsmann, Lukas, Ma, Jing, Belka, Claus, Su, Chuan, Li, Minglun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425706/ https://www.ncbi.nlm.nih.gov/pubmed/34513318 http://dx.doi.org/10.1080/2162402X.2021.1964189

Ejemplares similares

Hypofractionated Radiotherapy for Anaplastic Thyroid Cancer: Systematic Review and Pooled Analysis
por: Oliinyk, Dmytro, et al.
Publicado: (2020)

Clinical Outcome and Toxicity in the Treatment of Anaplastic Thyroid Cancer in Elderly Patients
por: Augustin, Teresa, et al.
Publicado: (2020)

Role of surgery to the primary tumor in metastatic anaplastic thyroid carcinoma: pooled analysis and SEER-based study
por: Oliinyk, Dmytro, et al.
Publicado: (2022)

Tumor microenvironment characterization in head and neck squamous carcinoma reveals distinct genomic alterations and clinical outcomes
por: Shi, Run, et al.
Publicado: (2020)

Identification and validation of hypoxia-derived gene signatures to predict clinical outcomes and therapeutic responses in stage I lung adenocarcinoma patients
por: Shi, Run, et al.
Publicado: (2021)

APOBEC-mediated mutagenesis is a favorable predictor of prognosis and immunotherapy for bladder cancer patients: evidence from pan-cancer analysis and multiple databases
por: Shi, Run, et al.
Publicado: (2022)

Cell cycle progression score as a predictive biomarker for overall survival in patients with adrenocortical carcinoma
por: Sun, Jing, et al.
Publicado: (2020)

Elective nodal radiotherapy with a gapless radiation field junction for oligorecurrent prostate cancer after previous radiotherapy
por: Li, Minglun, et al.
Publicado: (2022)

Excellent local control and survival after postoperative or definitive radiation therapy for sarcomas of the head and neck
por: Andrä, Claudia, et al.
Publicado: (2015)

Maximum standardized uptake value of primary tumor (SUVmax_PT) and horizontal range between two most distant PET-positive lymph nodes predict patient outcome in inoperable stage III NSCLC patients after chemoradiotherapy
por: Roengvoraphoj, Olarn, et al.
Publicado: (2020)

Planning target volume as a predictor of disease progression in inoperable stage III non-small cell lung cancer patients treated with chemoradiotherapy and concurrent and/or sequential immune checkpoint inhibition
por: Taugner, Julian, et al.
Publicado: (2021)

The Immune Landscape of Papillary Thyroid Cancer in the Context of Autoimmune Thyroiditis
por: Pani, Fabiana, et al.
Publicado: (2022)

The role of PDGF in radiation oncology
por: Li, Minglun, et al.
Publicado: (2007)

The ProMotion LMU dataset, prostate intra-fraction motion recorded by transperineal ultrasound
por: Ballhausen, Hendrik, et al.
Publicado: (2019)

Papillary Thyroid Carcinoma: Molecular Distinction by MicroRNA Profiling
por: Galuppini, Francesca, et al.
Publicado: (2022)

A Novel Gene Signature-Based Model Predicts Biochemical Recurrence-Free Survival in Prostate Cancer Patients after Radical Prostatectomy
por: Shi, Run, et al.
Publicado: (2019)

Implementation of durvalumab maintenance treatment after concurrent chemoradiotherapy in inoperable stage III non-small cell lung cancer (NSCLC)—a German radiation oncology survey
por: Käsmann, Lukas, et al.
Publicado: (2020)

Timing of tumor-induced atelectasis resolution and pulmonary function restoration in the course of image-guided moderate hypofractionated thoracic irradiation: a case report and mini-review of literature
por: Bodensohn, Raphael, et al.
Publicado: (2021)

Radiation-Induced Lung Injury: Prevention, Diagnostics and Therapy in the Era of the COVID-19 Pandemic
por: Käsmann, Lukas, et al.
Publicado: (2022)

Characterization of the Immune Cell Infiltration Landscape of Thyroid Cancer for Improved Immunotherapy
por: Gong, Jing, et al.
Publicado: (2021)

Differential role of residual metabolic tumor volume in inoperable stage III NSCLC after chemoradiotherapy ± immune checkpoint inhibition
por: Unterrainer, Marcus, et al.
Publicado: (2021)

Establishment and Validation of an Individualized Cell Cycle Process-Related Gene Signature to Predict Cancer-Specific Survival in Patients with Bladder Cancer
por: Shi, Run, et al.
Publicado: (2020)

Intra-fraction motion of the prostate is not increased by patient couch shifts
por: Ballhausen, Hendrik, et al.
Publicado: (2016)

Dosimetric impact of intrafraction motion on boosts on intraprostatic lesions: a simulation based on actual motion data from real time ultrasound tracking
por: Ballhausen, Hendrik, et al.
Publicado: (2019)

The ProMotion LMU dataset (2022 edition), prostate intra-fraction motion recorded by transperineal ultrasound
por: Ballhausen, Hendrik, et al.
Publicado: (2022)

Comprehensive Analysis of the Transcriptional and Mutational Landscape of Follicular and Papillary Thyroid Cancers
por: Yoo, Seong-Keun, et al.
Publicado: (2016)

The Genomic Landscape of Radioactive Iodine Refractory and Avid Papillary Thyroid Carcinomas
por: Al-Kuraya, Khawla Sami, et al.
Publicado: (2021)

Transcriptomic signatures associated with autoimmune thyroiditis in papillary thyroid carcinoma and cancer immunotherapy-induced thyroid dysfunction
por: Li, Yi, et al.
Publicado: (2022)

Treatment for papillary thyroid microcarcinoma
por: Shi, Lan, et al.
Publicado: (2013)

Papillary Thyroid Carcinoma Landscape and Its Immunological Link With Hashimoto Thyroiditis at Single-Cell Resolution
por: Pan, Jun, et al.
Publicado: (2021)

The Genomic Landscape of Thyroid Cancer Tumourigenesis and Implications for Immunotherapy
por: Singh, Amandeep, et al.
Publicado: (2021)

Planning CT Identifies Patients at Risk of High Prostate Intrafraction Motion
por: Ballhausen, Hendrik, et al.
Publicado: (2023)

Prophylactic cranial irradiation in small-cell lung cancer: update on patient selection, efficacy and outcomes
por: Manapov, Farkhad, et al.
Publicado: (2018)

Association of Planning Target Volume with Patient Outcome in Inoperable Stage III NSCLC Treated with Chemoradiotherapy: A Comprehensive Single-Center Analysis
por: Karin, Monika, et al.
Publicado: (2020)

Durvalumab after Chemoradiotherapy for PD-L1 Expressing Inoperable Stage III NSCLC Leads to Significant Improvement of Local-Regional Control and Overall Survival in the Real-World Setting
por: Taugner, Julian, et al.
Publicado: (2021)

Spontaneous Regression of Metastatic Papillary Thyroid Cancer in a Lymph Node
por: Shim, Jien, et al.
Publicado: (2018)

Pembrolizumab-induced myocarditis in a patient with malignant mesothelioma: plasma exchange as a successful emerging therapy—case report
por: Schiopu, Sanziana R. I., et al.
Publicado: (2021)

Clinical Management and Outcome of Grade III Pneumonitis after Chemoradioimmunotherapy for Inoperable Stage III Non-Small Cell Lung Cancer—A Prospective Longitudinal Assessment
por: Kauffmann-Guerrero, Diego, et al.
Publicado: (2021)

E2F8, a direct target of miR-144, promotes papillary thyroid cancer progression via regulating cell cycle
por: Sun, Jing, et al.
Publicado: (2017)

Identification of potential therapeutic targets for papillary thyroid carcinoma by bioinformatics analysis
por: ZHAO, MING, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_1hf0qtbcvqpm9kp7mpgbh9tgmt